英文名稱(chēng) Anti-CHRNA9

中文名稱(chēng) 煙堿型乙酰膽堿受體α9/AChRα9抗體

濃 度 1mg/1ml

規(guī) 格 0.2ml/200μg

抗體來(lái)源 Rabbit

克隆類(lèi)型 polyclonal

交叉反應(yīng) Human, Mouse, Rat, Chicken, Dog, Pig, Cow, Horse,Rabbit

產(chǎn)品類(lèi)型 一抗

研究領(lǐng)域 神經(jīng)生物學(xué) 通道蛋白 細(xì)胞膜受體 淋巴細(xì)胞 t-淋巴細(xì)胞b-淋巴細(xì)胞

蛋白分子量 predicted molecular weight: 52kDa

性 狀 Lyophilized or Liquid

免 疫 原 KLH conjugated synthetic peptide derived from humanCHRNA9

亞 型 IgG

純化方法 affinity purified by Protein A

儲(chǔ) 存 液 Preservative: 15mM Soium zde, Constituents: 1% BSA,0.01M PBS, pH 7.4

產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500IHC-F=1:100-500 Flow-Cyt=1:100-500 ICC=1:100-500 IF=1:100-500

（石蠟切片需做抗原修復(fù)）

not yet tested in other applications.

optimal dilutions/concentrations should be determined by theend user.

保存條件 Store at -637 °C for oneyear.

別 名 Cholinergic receptor nicotinic alpha 9; Cholinergicreceptor nicotinic alpha polypeptide 9; HSA243342; MGC142109; MGC142135; NACHRalpha 9; NACHRA9; Neuronal acetylcholine receptor protein subunit alpha 9precursor; ACHA9_HUMAN.